22,263
edits
Changes
Jump to navigation
Jump to search
m
decapitalize category names
HP802-247 is an experimental spray treatment for venous leg ulcers. The potential value of this spray is that it could treat those people whose skin will not heal with conventional treatment (such as compression bandages and dressings), and for whom the only alternative option could be skin graft.<ref>{{REFweb
| last= | first= | date=2012-08-03 | title=Spray-on-skin' treatment for leg ulcers | url=http://www.nhs.uk/news/2012/08august/pages/spray-on-skin-treatment-for-leg-ulcers.aspx | publisher=NHS | accessdate=2012-11-24
}}</ref>
The study was conducted by researchers from the University of Miami and other institutions in the US and was funded by Healthpoint Biotherapeutics, a biotech company that specialises in wound care products. The study was published in the peer-reviewed medical journal The Lancet.<ref>{{REFweb
| last= | first= | date=201209 | title=Spray-applied cell therapy with human allogeneic fibroblasts and keratinocytes for the treatment of chronic venous leg ulcers: a phase 2, multicentre, double-blind, randomised, placebo-controlled trial | url=http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(12)60644-8/abstract | publisher=The Lancet | accessdate=2012-11-24
}}</ref>
{{REF}}
[[Category:Foreskin Productsproducts]][[Category:Financial Gaingain]]
[[Category:From CircLeaks]]
[[Category:From IntactWiki]]